Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy.
Shuhong QiHui LiLisen LuZhongyang QiLei LiuLu ChenGuanxin ShenLing FuQingming LuoZhihong ZhangPublished in: eLife (2016)
The combined-immunotherapy of adoptive cell therapy (ACT) and cyclophosphamide (CTX) is one of the most efficient treatments for melanoma patients. However, no synergistic effects of CTX and ACT on the spatio-temporal dynamics of immunocytes in vivo have been described. Here, we visualized key cell events in immunotherapy-elicited immunoreactions in a multicolor-coded tumor microenvironment, and then established an optimal strategy of metronomic combined-immunotherapy to enhance anti-tumor efficacy. Intravital imaging data indicated that regulatory T cells formed an 'immunosuppressive ring' around a solid tumor. The CTX-ACT combined-treatment elicited synergistic immunoreactions in tumor areas, which included relieving the immune suppression, triggering the transient activation of endogenous tumor-infiltrating immunocytes, increasing the accumulation of adoptive cytotoxic T lymphocytes, and accelerating the infiltration of dendritic cells. These insights into the spatio-temporal dynamics of immunocytes are beneficial for optimizing immunotherapy and provide new approaches for elucidating the mechanisms underlying the involvement of immunocytes in cancer immunotherapy.
Keyphrases
- cell therapy
- regulatory t cells
- dendritic cells
- stem cells
- mesenchymal stem cells
- high resolution
- end stage renal disease
- immune response
- chronic kidney disease
- ejection fraction
- klebsiella pneumoniae
- newly diagnosed
- cancer therapy
- flow cytometry
- single cell
- high dose
- escherichia coli
- machine learning
- bone marrow
- patient reported outcomes